# Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke

> **NCT05369533** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 25 (actual)

## Conditions studied

- Stroke

## Interventions

- **DEVICE:** Telerehabilitation
- **DRUG:** Sinemet Pill
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05369533
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-01
- **Primary completion:** 2024-03-11
- **Final completion:** 2024-03-11
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05369533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05369533, "Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05369533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*